Association of Prediagnostic Blood Metabolomics with Prostate Cancer Defined by ERG or PTEN Molecular Subtypes

BACKGROUND: The TMPRSS2:ERG gene fusion and PTEN loss are two of the most common somatic molecular alterations in prostate cancer. Here, we investigated the association of prediagnostic-circulating metabolomics and prostate cancer defined by ERG or PTEN status to improve understanding of these etiol...

Full description

Bibliographic Details
Main Authors:	Feng, Xiaoshuang (Author), Zhou, Cindy Ke (Author), Clish, Clary B. (Author), Wilson, Kathryn M. (Author), Pernar, Claire H. (Author), Dickerman, Barbra A. (Author), Loda, Massimo (Author), Finn, Stephen P. (Author), Penney, Kathryn L. (Author), Schmidt, Daniel R. (Author), Heiden, Matthew G. Vander (Author), Giovannucci, Edward L. (Author), Ebot, Ericka M. (Author), Mucci, Lorelei A. (Author)
Format:	Article
Language:	English
Published:	American Association for Cancer Research (AACR), 2022-02-09T16:15:22Z.
Subjects:	Article
Online Access:	Get fulltext

by Feng, Xiaoshuang, Zhou, Cindy Ke, Clish, Clary B, Wilson, Kathryn M, Pernar, Claire H, Dickerman, Barbra A, Loda, Massimo, Finn, Stephen P, Penney, Kathryn L, Schmidt, Daniel R, Heiden, Matthew G Vander, Giovannucci, Edward L, Ebot, Ericka M, Mucci, Lorelei A
Published 2021

Get fulltext

Article

Association of Prediagnostic Blood Metabolomics with Prostate Cancer Defined by ERG or PTEN Molecular Subtypes

Similar Items